Drug Type Non-recombinant coagulation factor |
Synonyms- |
Target |
Mechanism Fibrinogen stimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (27 Sep 2017), |
Regulation- |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Afibrinogenemia | CN | 27 Sep 2017 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acquired fibrinogen deficiency | Discovery | CN | 30 Dec 2014 |